期刊文献+

氨磷汀对顺铂和环磷酰胺诱导正常细胞毒性的保护作用 被引量:1

The effect of amifostine on the cytotoxicity from cisplatine and cyclophosphamide
暂未订购
导出
摘要 目的 :评价氨磷汀对顺铂和环磷酰胺诱导正常细胞毒性的保护作用及对化疗药物抗肿瘤作用的影响。方法 :用MTT法测定顺铂对体外培养的Hela、Ho 8910肿瘤细胞的抑制作用 ,实验组加顺铂前 3 0min经氨磷汀处理 ,对照组则不需处理 ,比较两组细胞增殖的抑瘤率。同时观察注射顺铂、环磷酰胺前 3 0min注射氨磷汀与不注射组小鼠骨髓有核细胞的微核率。结果 :用 60 0mg·L- 1 氨磷汀在体外加顺铂前 3 0min加入Hela、Ho 8910肿瘤细胞 ,和对照组比较两组的肿瘤细胞增殖没有差异(P >0 .0 5 ) ;而体内实验得到 ,顺铂、环磷酰胺腹腔注射正常小鼠前 3 0min注射氨磷汀与不注射氨磷汀比较 ,单独用顺铂、环磷酰胺的小鼠骨髓有核红细胞微核率高于氨磷汀保护组 (P <0 .0 5 )。结论 :氨磷汀腹腔注射正常小鼠可明显降低顺铂、环磷酰胺引起正常小鼠的细胞毒性 ,同时氨磷汀不影响顺铂对Hela、Ho 8910肿瘤细胞的化疗疗效。 Objective To evaluated the protective ability of amifostine on cytotoxicities due to chemotherapy without affecting its tumorcidal effect. Methods Two cell lines(Hela,Ho-8910) were exposed to cisplatine. Cell were pretreated with either 0 or 600、mg·L -1 amifostine. Tumorcidal effect in two groups was measured using the MTT assay.The mice were pretreated with amifostine 30 minutes before each cisplatine and cyclophosphamide in the test group, while mice in control group were not pretreated with amifostine. The micronuclei of mice was observed in two groups. Results There was no significant difference in antitumor effect between drug-treated samples with and without pretreatment with amifostine(P>0.05). The incidence rate of micronuclei of mice in control group were significantly higher than that of the test group(P<0.05). Conclusion Amifostine protects against a spectrum of cytotoxicities in mice induced by cisplatine and cyclophosphamide it without affecting tumorcidal effect.
出处 《东南大学学报(医学版)》 CAS 2004年第5期314-316,共3页 Journal of Southeast University(Medical Science Edition)
关键词 氨磷汀 顺铂 环磷酰胺 细胞毒性 保护作用 抗肿瘤药 amifostine cisplatine cyclophosphamide chemotherapy cytotoxicity micronuclei rate mice
  • 相关文献

参考文献9

  • 1PIERELLI L, SCAMBIA G, FATTOROSSI A, et al. In vitro effect of amifostine on haematopocetic progenitore exposed to carboplatin and non-alkylating antineoplastic druge: haematoprotection acts as a drug-specific progenitor resue[J]. Br J Cancer,1998,78(88):
  • 2MAZUR L. Radioprotective effect of the thiole GSH and WR-2721 and against X-ray induction of micronuclei in erythrobluste[J]. Mutat Res, 2000,468(1):27-33.
  • 3CAPIZZI R L. The preclinical basis for broad-spectrum selective cytoprotection of normal tissue from cytotoxic therapies by amifostine[J]. Semin Oncol,1999,26(Suppl 7):3-21.
  • 4MARZATICQ F, PORTA C, MORONI M, et al. In vitro antionidant properties of amifostine(WR-2721,Ethyol)[J]. Cancer Chemother Pharmacol,2000,45(2):172-176.
  • 5NG T Y, NGAN H Y, CHENG D K, et al. The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell line[J]. Gynecol Oncol,1999,75(2):194-197.
  • 6MAZUR L, BLAWAT A. Effects of GSH and WR-2721 on in-duction of micronuclei by cyclophosphamide[J]. Toxicol Lett, 1999,110(1-2):67-72.
  • 7MAZUR L, CZYZEWSKA A. Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice[J]. Mutat Res, 1994,309(2):219-223.
  • 8MAZUR L. Induction of micronucleated erythrocytes by MEA,AET,WR-2721 and X-rays[J]. Mutat Res, 1995,334(3):0317-322.
  • 9马培奇.细胞保护剂氨磷汀及其临床应用与展望[J].中国肿瘤,2001,10(8):471-472. 被引量:9

二级参考文献3

  • 1[1]Spencer CM,Goa KL Amifostine.A review of its pharmacodynamic andpharmacokinetic properties,and therapeutic potential as a radioprotectorand cytotoxic chemoprotector[J].Drugs,1995,50(6):1001-1031.
  • 2[2]Kemp G,Rose P,Lurain J,et al.Amifostine pretreatment for protection againstcyclophosphamide induced and cisplatin-induced toxicities:results of a randomized control trial in patients withadvanced ovarian cancer[J].J Clin Oncol,1996,14(7):2101-2112.
  • 3[3]Hoekman K,van der Vijgh WJ,Vermorken JB.Clinical and preclinical modulationof chemotherapy induced toxicity in patients withcancer[J].Drugs,1999,57(2):133-155.

共引文献8

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部